CNSY earnings analysis
What we found in CNSY's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q extract is limited primarily to Part II and does not include income-statement, balance-sheet, cash-flow, segment, or MD&A financial data; therefore revenue, margins, EPS, cash flow, and working-capital trends cannot be assessed from the filing text provided. Disclosure controls were deemed effective as of June 30, 2026, with no material changes in internal control over financial reporting. Management reported no legal proceedings and no material changes to the risk factors from the 2025 Form 10-K, while the filing provides no quantitative guidance.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Disclosure controls deemed effective
- Management concluded that disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2026.
- No material control changes
- The company reported that there were no changes in internal control over financial reporting during the quarter ended June 30, 2026, that materially affected or were reasonably likely to materially affect those controls.
- No legal proceedings reported
- The filing reports no legal proceedings under Part II, Item 1.
- No reported equity transactions
- The company reported no unregistered sales of equity securities, no use of proceeds from registered securities, and no purchases of equity securities during the reporting period.
- Lease amendment filed
- The filing includes a First Amendment to the lease dated August 10, 2026, as Exhibit 10.3, with portions redacted under Item 601(b)(10)(iv) of Regulation S-K.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- No updated risk-factor disclosure
- The filing states, verbatim, that there have been no material changes to the risk factors disclosed in Part I, Item 1A of the 2025 Form 10-K. Accordingly, no new or modified risk-factor disclosure was identified in this 10-Q.
- Equity distribution financing risk
- The company filed an Equity Distribution Agreement with Canaccord Genuity LLC dated June 1, 2026. The supplied extract does not disclose sales under the agreement or its remaining capacity, so potential financing-related dilution cannot be quantified.
- Recent corporate charter changes
- The filing includes a Certificate of Amendment to the Amended and Restated Certificate of Incorporation effective August 3, 2026, and Second Amended and Restated Bylaws filed August 4, 2026; the supplied extract does not explain their economic implications.
What they said about what is next.
No quantitative revenue or EPS outlook is disclosed in the supplied 10-Q extract; numeric guidance fields are therefore null.
The filing reads about the same as the one before it.
What came before.
- 10-Q · October 30, 2025
- The extracted filing text does not include the financial statements or MD&A, so revenue, margins, EPS, balance-sheet trends, cash flow, and segment performance cannot be assessed. Nasdaq confirmed compliance with the…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing CNSY makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever